Most Liquid Health Care Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1GEHC GE HealthCare Technologies
1.51 B
(0.02)
 1.36 
(0.03)
2MURA Mural Oncology plc
284.39 M
 0.02 
 2.58 
 0.06 
3ARDT Ardent Health Partners,
281.96 M
(0.05)
 3.49 
(0.19)
4AUNA Auna SA
253.19 M
(0.01)
 2.71 
(0.03)
5NAMS NewAmsterdam Pharma
230.98 M
 0.10 
 3.60 
 0.36 
6SYRE Spyre Therapeutics
198.34 M
 0.02 
 3.68 
 0.06 
7IMTXW immatics biotechnologies GmbH
178.39 M
(0.22)
 10.70 
(2.33)
8BKDT Brookdale Senior Living
163.94 M
(0.14)
 2.67 
(0.36)
9TRML Tourmaline Bio
147.76 M
 0.14 
 4.10 
 0.58 
10WGS GeneDx Holdings Corp
146.46 M
 0.20 
 7.58 
 1.50 
11WGSWW GeneDx Holdings Corp
146.46 M
 0.30 
 11.92 
 3.58 
12GRAL GRAIL, LLC
139.75 M
 0.06 
 3.76 
 0.23 
13DNTH Dianthus Therapeutics
138.94 M
(0.08)
 3.82 
(0.31)
14GPCR Structure Therapeutics American
136.28 M
(0.06)
 4.24 
(0.24)
15BRNS Barinthus Biotherapeutics plc
133.15 M
(0.06)
 5.76 
(0.35)
16BCAX Bicara Therapeutics Common
129.03 M
 0.03 
 5.80 
 0.16 
17AVBP ArriVent BioPharma, Common
128.72 M
 0.01 
 3.68 
 0.05 
18HUMAW Humacyte
127.9 M
(0.01)
 7.15 
(0.07)
19SOLV Solventum Corp
126.87 M
 0.16 
 1.62 
 0.26 
20KRRO Frequency Therapeutics
120.47 M
 0.05 
 12.72 
 0.63 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).